Study Title

HERPET: A Mechanistic Non-Invasive Imaging Study of HER2 Expression in Breast Cancer Using [18F]GE-226 Positron Emission Tomography

Study Details

Description:

This mechanistic study will be the first study to assess the efficacy of [18F]GE-226 to target HER2 expression in patients with metastatic breast cancer. The study will establish the pharmacokinetics of [18F]GE-226 and the optimum time-point for performing static scans in this patient population.

Sponsor:

Imperial College London

Contacts:

HERPET Trial Coordinator

herpet@imperial.ac.uk

Gosala Gopalakrishnan, PhD

g.gopalakrishnan@imperial.ac.uk

0207 59 42804

Government Study Link:

NCT03827317 - Click here to see study on

ClinicalTrials.gov

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468